Cartaciano, Julie Mae J.
HRN: 09-58-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/17/2023
CEFUROXIME 1.5GM (VIAL)
04/17/2023
04/18/2023
IVTT
1.5gm
3 Doses
Post-op Prophylaxis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes